Acute External Ventricular Drain Market Worth $432.69 Million By 2030

Acute External Ventricular Drain Market Growth & Trends

Acute External Ventricular Drain Market Report Highlights

  • By application, Traumatic Brain Injury (TBI) accounted for the largest revenue share of 33.78% in 2021. This is due to the increasing prevalence of TBI along with an increase in the number of surgeries globally
  • Based on patient type, the pediatric patient type segment is expected to grow at the fastest CAGR of 8.02% from 2022 to 2030,due to an increase in the number of surgical procedures to treat hydrocephalus in newborn babies. For instance, according to Pediatric Neurosurgery, approximately 69,000 hospital discharges of patients with hydrocephalus are reported each year in the U.S.
  • Asia Pacificacute external ventricular drain market is expected to witness the fastest CAGR of 8.26% over the forecast period. This can be attributed to the increasing awareness and rising investment of key players in the developed and emerging nations, which are some of the major factors responsible for the significant growth rate during the forecast period
  • The industry is highly competitive with players including Medtronic, Integra LifeSciences Corporation, Natus Medical Incorporated, Fuji Systems, Spiegelberg GmbH, SOPHYSA, and Neuromedex

--

--

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
Rajesh Varma

Hello guys I am Market Research Analyst @ Grand View Research, preparing and publish research report on Technology, Next Generation Technologies